EMBC | EmbectaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$6.08
-$0.11 (-1.78%)

Embecta (EMBC) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Jan 2026, but the two have been closing on each other and a golden cross is projected within 30 bars. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $6.08 vs 50 $5.78 / 200 $6.37
Projection
Golden cross estimated in 16 to 22 bars
Test
No active test
Last cross
Death cross 28 Jan 2026 ยท projected 24 bars out ยท tested 1 bar

Weekly as of 30 Oct 16:00 ET

Price
below both $6.25 vs 50 $7.44 / 200 $14.61
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
between the two $6.08 vs 50 $6.22 / 200 $4.76
Projection
No cross projected
Test
No active test
Last cross
Golden cross 1 Sep 2026 ยท projected 30 bars out

Cross history

20
crosses on record since 2023
10 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Sep 2026Golden4-hour30 bars outNot tested
28 Jan 2026Death moderatedaily24 bars out1 bar cross test
9 Dec 2025Death4-hour17 bars outNot tested
7 Oct 2025Golden steepdaily30 bars out6 bar cross test
19 Aug 2025Golden4-hour27 bars outโ€”

About EMBC

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$6.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.